We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

For income investors, 2020 will be a dividend drought

FTSE 100-only income investors have taken a pummelling.

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

In mid-February, investment firm Janus Henderson published its usual quarterly global dividend review.

2020, judged the firm, looked set to deliver a fifth consecutive year of record dividends, with global payouts totalling of $1.48 trillion expected, some 3.9% higher than 2019.

Should you buy Rolls Royce shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

But that was then; this is now.

Three months on, the more sober assessment of 2020 contained in the firm’s latest global dividend review is a great deal more downbeat. Its best case scenario sees a decline in global dividends of 15% this year to $1.21 trillion, a drop of $213bn. Its worst case scenario sees a decline of 35%, $933bn.

In hindsight, it’s easy to be critical. For a review published in mid-February to contain not a single mention of the words ‘coronavirus’, ‘Covid-19’, or ‘pandemic’ seems in retrospect a little shortsighted.

But hey, plenty of other people have also been wrong about Covid-19. Most of us, in fact, one way or another.

Global perspective

If you’re not familiar with the quarterly Janus Henderson reviews, they’re worth checking out.

Basically, they take a country-by-country, region-by-region bottom-up focus to dividend projection, looking at business conditions, trade, economic growth and other factors bearing on corporate earnings.

So while they’re similar in many ways to the familiar re-branded Capita UK-only forecasts that are now published under the name of Link Asset Services, they’re a little more forward-looking.

Usefully, they also contain the Janus Henderson Global Dividend Index. Standing at 196.3 at the end of March, this highlights that global dividends have almost doubled since 2009, when the index began.

Different outcomes

But let’s go back for a moment to those best-case and worse-case scenarios — and in particular, to that worse-case scenario projecting a 35% decline in global dividend income in 2020.

Obviously, it’s a figure that could be wrong: frankly, no one knows. But accepting it at face value for moment, it’s worth comparing with Link Asset Services’ own UK-specific forecast, which projects UK dividend income falling by more than half.

Obviously, Link Asset Services’ figures could be wrong, too, but the contrast between the two estimates is difficult to ignore.

Global equity income investors are going to see a worst-case fall in income of around 35%; UK equity income-investors are going to see a fall of 55% or so. That’s quite a gap.

Footsie fallout

 A lot of UK equity income investors have portfolios heavily biased to the upper reaches of the FTSE 100.
 
That’s not surprising, of course, and apart from anything else reflects the prominent role of big dividend payers such as Royal Dutch Shell, HSBC, GlaxoSmithKline, and British American Tobacco.
 
The trouble is that a number of these dividend stalwarts have abruptly fallen — or been pushed, in HSBC’s case — off their pedestals.
 
Overall, last time I looked, some 45% of the FTSE 100 had cancelled, reduced, or delayed their dividend payments. Including two of the four above: Shell, slashing by two-thirds; and HSBC, cutting completely.
 
Thankfully, my own investments have been buffered by some judicious holdings of industrial REITs and a number of investment trusts. Even so, I’ve not been immune.

Overseas earnings

There are good reasons for Janus Henderson to expect some other regions of the world to be less badly affected by the coronavirus crisis, from a dividend-paying perspective. Their sectoral and regional analysis, covering several pages, is persuasive. Time will tell if the firm’s reasoning was valid.

What’s beyond argument, though, is that global income investors are going to be a lot more diversified than UK-only income investors. Home-country bias may be comfortable, but at a time like this one begins to see its drawbacks.
 
Going global isn’t without its risks, of course. Currency risk. Taxation risk. Political risk. Volatility risk. So plunging headlong into foreign shares isn’t for the faint-hearted.
 
But going forward, I expect many more investors to start taking an interest in overseas shares — dabbling in them first, perhaps, by taking a look at global investment trusts such as Aberdeen Asian Income, JP Morgan European Income, Henderson Far East Income, Schroder Oriental Income, and Murray International.
 
‘You can be sure of Shell,’ was the saying, back when I was growing up. Not any more, you can’t.

Malcolm owns shares in Royal Dutch Shell, HSBC, GlaxoSmithKline, Aberdeen Asian Income, JP Morgan European Income, Henderson Far East Income, Schroder Oriental Income, and Murray International.

More on Investing Articles

A row of satellite radars at night
Investing Articles

This ex-penny stock has crushed Rolls-Royce shares over 5 years! Is there more to come?

With all eyes on Rolls-Royce shares, this growth share with a connection to SpaceX might have gone unnoticed by a…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

With a 6.4% yield and P/E of 10 is this FTSE dividend stock a hidden passive income gem?

Building a portfolio of solid UK dividend stocks isn't hard. Paul Summers takes a closer look at one high-yielding candidate…

Read more »

Black woman using smartphone at home, watching stock charts.
Growth Shares

At 112p, where next for the Lloyds share price? 168p or 56p?

Jon Smith mulls over the direction going forward for the Lloyds share price, and explains why two very different scenarios…

Read more »

Investing Articles

This dividend stock has a 7.3% yield, and Stocks and Shares ISA investors are buying!

Looking to move from a Cash ISA to a Stocks and Shares ISA to target passive income? Alan Oscroft has…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

Could Rolls-Royce shares lock in another 34% gain before Christmas?

Mark Hartley takes a look at some of the more optimistic price targets for Rolls-Royce, and considers a best-case scenario.…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »